Exclusive: Spot Bio launches with $40M to study mRNA therapy for muscular dystrophy Jun 17 Written by Andrew Lee Read the article Andrew Lee Next Next Spot Biosystems Launches with $40 Million Financing and World-First Non-Viral Delivery of Full-Length Dystrophin in Animal Models and Human Patients with DMD
Exclusive: Spot Bio launches with $40M to study mRNA therapy for muscular dystrophy Jun 17 Written by Andrew Lee Read the article Andrew Lee